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Allerton TD, Kowalski GM, Hang H, Stephens J. Dynamic
glucose disposal is driven by reduced endogenous glucose production
in response to voluntary wheel running: a stable isotope approach. Am
J Physiol Endocrinol Metab 319: E2–E10, 2020. First published April
28, 2020; doi:10.1152/ajpendo.00450.2019.—To resolve both the
systems level and molecular mechanisms responsible for exerciseinduced improvements in glucose tolerance, we sought to test the
effect of voluntary wheel running exercise on postprandial glucose
dynamics. We utilized a stable isotope-labeled oral glucose tolerance
test (SI-OGTT) incorporating complementary deuterium glucose tracers at a 1:1 ratio (2-2H-glucose and 6 – 6 2H-glucose; 2g/kg lean body
mass) to distinguish between endogenous glucose production (EGP)
and whole-body glucose disposal. SI-OGTT was performed in
C57BL/6J mice after 8 wk on a high-fat diet (HFD; 45% fat). Mice
were then randomized to either a wheel-running cage (n ⫽ 13, HFD
Ex) or a normal cage (n ⫽ 13, HFD Sed) while maintaining the HFD
for 4 wk before performing a SI-OGTT. HFD Ex mice demonstrated
improvements in whole blood glucose total area under the curve
(AUC) that was attributed primarily to a reduction in EGP AUC.
Serum insulin levels measured at 0 and 15 min post- glucose gavage
were significantly elevated in the HFD Sed mice, whereas HFD Ex
mice demonstrated the expected reduction in insulin at both time
points. Overall, exercise improved hepatic insulin sensitivity by reducing postprandial EGP, but also increased whole-body glucose
disposal. Finally, these results demonstrate the benefits of exercise on
hepatic insulin sensitivity by combining a more physiological route of
glucose administration (oral glucose) with the resolution of stable
isotope tracers. These novel observations clearly demonstrate that
SI-OGTT is a sensitive and cost-effective method to measure exercise
adaptations in obese mice with as little as 2 l of tail blood.
exercise; glucose tolerance; stable isotopes; voluntary wheel running

INTRODUCTION

Pre-diabetes and type 2 diabetes (T2D) are characterized by
fasting and postprandial hyperglycemia (6). Under physiological postprandial conditions, increased blood glucose concentrations stimulate insulin secretion to reduce endogenous glucose production (EGP), enhance muscle glucose uptake, and
reduce adipose tissue lipolysis in a coordinated manner to
dispose of exogenous glucose and restore euglycemia. Persistent hyperglycemia, in both the fasting and postprandial state,
are thought to be responsible for the increased prevalence of
vascular disease in subjects with T2D (34). Notably, it appears
that individuals with normal fasting glucose yet impaired
glucose tolerance (IGT; pre-diabetes) already demonstrate
Correspondence: T. D. Allerton (timothy.allerton@pbrc.edu).
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signs of endothelial dysfunction and other diabetes related
complications (1). Therefore, strategies for improving postprandial glucose metabolism are important for not only preventing the development of overt T2D but also for preventing
the complications of pre-diabetes.
Exercise is an effective strategy to increase insulin sensitivity and glucose tolerance in humans and animal models of
diet-induced obesity (DIO) and insulin resistance (16). Voluntary wheel running (VWR) is an exercise model (13, 14)
utilized to promote common exercise-mediated skeletal muscle
adaptations (i.e., mitochondrial content and function) (31).
Data from exercised rats shows consistent results for improved
whole body insulin sensitivity, but inconsistent benefits on
tissue-specific (i.e., muscle and liver) insulin sensitivity (11,
12, 23, 30). Furthermore, while it is well known that VWR can
restore glucose tolerance in DIO mice (3, 5, 41), there is little
mechanistic insight into the actual metabolic pathways responsible for the improvements in postprandial glucose handling in
this commonly used exercise model.
Dynamic glucose disposal is dependent on whole body
coordination of insulin action and insulin secretion, which
more accurately represent the transition from the fasted to fed
state (43, 44). DIO mice are known to develop hyperglycemia
and hyperinsulinemia and therefore present a model of insulin
resistance (29, 46). The euglycemic hyperinsulinemic clamp
method is a valuable tool to measure insulin action; however,
it fails to replicate dynamic endogenous hormone alterations
that occur during nutrient intake and may fail to elucidate
undetectable metabolic phenotypes (43). Furthermore, the
clamp method is an invasive procedure that does not lend itself
to repeated measures over time (25). Also, the technical expertise and demands of the methodology have greatly limited
its availability. Therefore, the aim of the current study was to
measure glucose dynamics in a common metabolic model, DIO
in C57BL/6J mice, before and after a period of VWR. We also
interrogated molecular signatures of exercise-induced adaptations in skeletal muscle and liver that have been implicated in
improved glucose handling.
MATERIALS AND METHODS

Animal housing and study design. The Pennington Biomedical
Research Center (PBRC) Animal Care and Use Committee approved all
study experiments. Four-week-old male C57BL/6J mice (n ⫽ 26) were
purchased (The Jackson Laboratory, Bar Harbor, ME) and housed in the
PBRC comparative biology core. Mice (4 wk old) were then multihoused
(4 to a cage) and placed on a 45% high fat diet (HFD; Research
Diet12451, New Brunswick, NJ) for 8 wk. Following the 8-wk HFD
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feeding period, mice were individually housed and randomly allocated to
either a HFD sedentary group (HFD Sed), one to a cage, with no
running wheel or a cage with free access to a running wheel (HFD Ex;
Minimitter, West Chester, PA) for 4 wk. Wheel revolutions were
counted each minute by a magnetic switch mechanism, and data were
stored using Vital View Software (version 4.0, Oakmont, PA). Body
weight and food intake were measured on a weekly basis. Food intake
was assessed by weighing food put it in the food hopper and then
weighing remaining food pellets and crumbs to determine the amount
ingested (47). Body composition was measured via NMR, and a stable
isotope-labeled oral glucose tolerance test (SI-OGTT) was performed
to get an index of dynamic glucose disposal and pattern of endogenous glucose production both after 8 wk of HFD feeding (Pre) and
again after 12 wk HFD feeding (Post; i.e., after 4 wk of exercise
intervention). At the end of the experiment, mice were euthanized by
isoflurane administration with cardiac puncture. A subgroup of mice
(n ⫽ 6, HFD Sed; n ⫽ 5, HFD Ex) from both groups was intraperitoneally injected with human insulin (Humulin, Eli Lilly, Indianapolis, IN) at a dose of 1.5 U/kg 10 min before euthanasia to examine
modulation of insulin signaling proteins.
SI-OGTT. To get a readout of the dynamic changes in glucose
disposal and patterns in endogenous glucose production (EGP), we
employed a SI-OGTT consisting of two complementary deuterium
glucose labels (2-[2H] and 6,6-[2H]; Cambridge Isotope, Tewksbury,
MA) at a 1:1 ratio as described previously (28). Briefly, mice were
fasted for 4 h and were then gavaged with a 1:1 ratio of the glucose
tracer at a total dose of 2 g/kg lean body mass. Tail blood glucose was
measured at 0, 15, 30, 45, 60, 90, and 120 min with a glucometer
(Bayer, Leverkusen, Germany). Unlabeled, 2-[2H]-glucose and 6,6[2H]-glucose concentrations were measured at 0, 15, 30, 60, and 120
min via gas chromatography-mass spectrometry (GS-MS). Serum
extraction was conducted in ice-cold analytic grade methanol to
precipitate proteins. Samples were then vortexed and centrifuge spun
at 3,000 rpm at 4°C for 10 min. The supernatant was then derivatized
via a hydroxylamine hydrochloride solution and acetic anhydride to
ensure complete acylation of hydroxyl groups. Fractional amounts of
(2-[2H] and 6,6-[2H] glucose tracers were determined via GC-MS and
a matrix method, while tracer concentrations over time were calculated by using measured plasma glucose concentrations. The processing method required an initial plasma sample volume of 2.5 L
combined with 100 L of chilled methanol to precipitate proteins. The
samples were then centrifuged at 3,000 rpm for 10 min at 4°C after
which 85 L of the supernatant was transferred into a 400 L glass
GC insert (Thermo Scientific, Rockwood, TN) and dried in a speed
vacuum at 37°C for 1 h (Labconco). Samples were derivatized by
adding 50 L of hydroxylamine hydrochloride (Sigma, St. Louis,
MO) in pyridine (30 mg/1 mL), vortexed for 10 s, and put in a 90°C
oven for 1 h. After the samples were removed from the oven and
allowed to cool for 10 min, 50 L of acetic anhydride was added to
the samples and they were incubated at 60°C for 30 min to ensure
complete acylation of hydroxyl groups. Next, samples were dried
down in a speed vacuum at 37°C for 1 h. The dried samples were then
resuspended in 150 L of butyl acetate for GCMS analysis using the
Agilent 7890A Gas Chromatography system with a DB-5 capillary
column installed (30 m, 0.25 mm, 0.25 m, J&W Scientific) and a
5975C inert XL EI/CI MSD with triple-axis detector (Agilent, Santa
Clara, CA). The samples were analyzed via positive chemical ionization using helium as the carrier gas and methane as the reagent gas.
Glucose enrichment was measured using molecular ions 328, 329, and
330 m/z, corresponding to naturally occurring glucose M0 (328),
[2-2H] tracer M1 (329), and [6,6-2H] tracer M2 (330). Selective ion
monitoring (SIM) was utilized with a 20-ms dwell time for each ion.
The samples were injected using the splitless mode with a constant
flow of 1 mL/min and a run time of 15 min. Ion abundances were
analyzed using the Quantitative Mass Hunter Workstation (Agilent).
Values obtained from ion peak integration were used to calculate
tracer fractional amounts and changes in concentration over time.

The use of stable isotope-labeled glucose permits the partitioning of the blood glucose concentration into the glucose derived
from endogenous (unlabeled)- and exogenous meal-derived (labeled) sources (28). A common feature of T2D in human and
rodents models is hepatic futile glucose cycling (7, 27). Whereby
glucose is normally phosphorylated via glucokinase and trapped in
the hepatocyte by investment of energy (1 ATP), hepatic futile
glucose cycling reflects the dephosphorylation of glucose by glucose-6-phosphatase and subsequent release back into the circulation. The isotopic position of [2-2H]-glucose can be recycled and
positioned on glucose leaving the hepatocyte. Whereas, [6,6-2H]glucose generally reflects glucose disposal because the 2H will not
be recycled back into the C-6 position (36). When provided in
equimolar amounts, the dual tracer approach can detect hepatic
futile glucose cycling by measuring the difference in [2-2H]glucose area under the curve (AUC) from the AUC [6,6-2H]glucose (27, 28).
Preparation of tissue extracts. At the time of necropsy, adipose
tissues, gastrocnemius muscle, and the liver were collected, weighed,
and frozen. Triacylglycerol (TAG) were measured in serum, muscle,
and the liver using a colorimetric assay (Eagle Biosciences, Amherst,
NH). Liver and muscle glycogen were processed by enzymatic hydrolysis and measured via a colorimetric assay (Abcam, Cambridge,
MA). Serum nonesterified fatty acids (NEFA) were quantified by the
Acyl-CoA oxidase method (Wako Chemical, Richmond, VA). Serum
insulin was measured by ELISA (Biovision, Milpitas, CA). The
homeostatic model analysis of insulin resistance (HOMA-IR) was
calculated by serum insulin (mmol/L) ⫻ blood glucose (mmol/L)/
22.5.
Protein and mRNA expression. Gastrocnemius and liver tissues
were powdered using a frozen mortar and pestle and homogenized in
a protein extraction buffer containing 150 mM NaCl, 10 mM Tris (pH
7.4), 1 mM EDTA, 1 mM EGTA, 0.5% IGEPAL CA-630, 1% Triton
X-100, 2 mM PMSF, 2 M pepstatin, 100 trypsin inhibitory mU of
aprotinin, 20 M leupeptin, 2 mM 1, 10-phenanthroline, 0.8 mM
sodium orthovanadate, and 400 M sodium fluoride. Tissue homogenates were then clarified using centrifugation at 13,000 g for 10 min
at 4°C and stored at ⫺80°C until analysis.
For RNA extraction, powdered tissues were homogenized in TRIzol (Life Technologies, Carlsbad, CA) followed by isolation using
standard phenol-chloroform extractions. RNA was then isolated using
the RNeasy Mini Kit (Qiagen, Hilden, Germany) and stored at ⫺80°C
until further analysis.
Immunoblotting. Protein concentrations from tissue homogenates
were quantified using a BCA Kit for Protein Determination (SigmaAldrich, St. Louis, MO). A total of 50 –100 g of protein were loaded
on 10% SDS-polyacrylamide gels (National Diagnostics, Atlanta,
GA) and transferred onto 0.45 m nitrocellulose membranes (BioRad, Hercules, CA). Membranes were blocked with 4% milk for 1 h
at room temperature and probed with antibodies listed in Table 1
overnight at 4°C. Proteins were detected using horseradish peroxidase-conjugated secondary antibodies (Jackson ImmunoResearch,
West Grove, PA) and SuperSignal West Pico PLUS reagents (Thermo
Fisher, Rockford, IL). Blots were imaged using X-ray film or the
ChemiDoc XRS⫹ Imaging System (Bio-Rad). Protein signals were

Table 1. List of antibodies used for immunoblotting
Supplier

Antibody

Source

Cell Signaling
Cell Signaling
Cell Signaling
Cell Signaling
Cell Signaling
Abclonal
R&D Systems

AKT
AKTpS473
AKTpS473
AMPK␣
AMPK␣pT172
PDK4
STAT5B

Mouse monoclonal
Mouse monoclonal
Rabbit polyclonal
Rabbit polyclonal
Rabbit polyclonal
Rabbit polyclonal
Rabbit polyclonal
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Table 2. Primer sequences for mRNA determination
Gene

Forward Primer

Reverse Primer

Cs
Foxo1
Mdh1
Mdh2
Nos3/Enos
Pdk4
Pepck/Pck1
Pgc1␣
Ppia
Tfam
Ubb

AGAACTCATCCTGCCTCGT
CTTCAAGGATAAGGGCGACAG
GGCACAGCCTTGGAGAAATA
GAAGGAGTCGTTGAGTGTTCTT
CTTGAGGATGTGGCTGTGT
CATCGCCAGAATTAAACCTCAC
GCCGAGACTAGCGATGGGGGT
TGCAGCCAAGACTCTGTATG
CCACTGTCGCTTTTCGCCGC
AAACCAAAAAGACCTCGTTCAG
CCAGTGGGCAGTGATGG

CCTGCTCCTTAGGTATCAGATTG
AGTTCCTTCATTCTGCACTCG
CTGGATACTGGGTCGATGAATG
CTCACACCTCTCACTTCATGTT
TGGTCCACTATGGTCACTTTG
GGCATTCTTGAAGAGTTCGAAG
TGGGCACATGGTTCCGCGTC
TCAGAAAGGTCAAGTTCAGGAAG
TGCAAACAGCTCGAAGGAGACGC
TTTCCAAGCCTCATTTACAAGC
GCTTACCATGCAACAAAACCT

Cs, citrate synthase; Foxo1, Forkhead Box O-1; Mdh1, malate dehydrogenase 1; Mdh2, malate dehydrogenase 2; NOS3, nitric oxide synthase; Pdk4, pyruvate
dehydrogenase kinase 4; Peck, phosphoenolpyruvate carboxykinase; Pgc1␣, peroxisome proliferator-activated receptor gamma coactivator 1-alpha; TFAM,
mitochondrial transcription factor A; Ppia, peptidylprolyl isomerase A; Ubb, ubiquitin b.

quantified in either Image Studio 5.2 (LI-COR Biosciences, Lincoln,
NE) or Image Laboratory 4.0 (Bio-Rad).
Gene expression analysis. RNA concentrations were quantified
using a NanoDrop ND-1000 UV-Vis Spectrophotometer. Reverse
transcription was performed using a High-Capacity cDNA Reverse
Transcription Kit (Applied Biosystems, Foster City, CA) with 2 g of
RNA. Quantitative PCR was performed using SYBR Premix with
ROX Plus (Takara Bio, Mountain City, CA) with 4 ng of cDNA and
run on the Applied Biosystems 7900HT system with SDS 2.4 software
(Applied Biosystems). Thermal cycling conditions were as follows: 2
min at 50°C, 10 min at 95°C, 40 cycles of 15 s at 95°C, and 1 min at
60°C; dissociation stage: 15 s at 95°C, 15 s at 60°C, and 15 s at 95°C.
Relative expression of genes were interpolated using standard curves,
and all target genes were normalized to the numerical average of Ppia

A
HFD Sed
HFD Ex

Body composition. At 4 wk of age, a group of 26 male mice
were group housed (4 to a cage) and placed on a 45% HFD for 8
wk. Following the 8-wk HFD feeding period, mice were individ-
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RESULTS

B
40
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(peptidyl prolyl isomerase A) and Ubb (ubiquitin B). The primers
(Integrated DNA Technologies, Coralville, IA) are found in Table 2.
Statistical analysis. An independent t test and repeated measures
two-way ANOVA were utilized to analyze data where appropriate
(Prism, Graphpad). Multiple comparisons were made by Holm–
Sidak’s test. Statistical significance was declared at P ⬍ 0.05. All data
were reported as means ⫾ SE. Calculations of incremental AUC were
made by the trapezoidal method.

1.5
HFD Sed

1.0

****

HFD Ex

****
****

0.5

****

****

0.0
Pre Post

Pre Post

iWAT

eWAT

rWAT

mWAT

BAT

Fig. 1. Voluntary wheel running (exercise) reduces fat mass. Four-week-old C57BL/6J male mice (group-housed) were placed on a 45% high-fat diet (HFD) for
8 wk. Mice were randomized and single housed in sedentary (Sed) or wheel running (Ex; bar with hashed lines) conditions for an additional 4 wk (12 wk total).
Body weight was measured weekly over the 12-wk experiment (A) as was food intake (B). NMR was utilized to measure body fat percentage (C), lean mass
(D), and body fluid (E). F: adipose tissue mass weights for inguinal (iWAT), epididymal (eWAT), mesenteric (mWAT), and reteroperitoneal (rWAT) white
adipose tissue. E: time effect refers to difference between pre- and postmeasurements. Activity effect refers to difference between Sed and Ex mice. Time ⫻
activity indicates an interaction. All data are expressed as means ⫾ SE. ***P ⬍ 0.001, ****P ⬍ 0.0001; n ⫽ 13/group.
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ually housed and randomly allocated to either a HFD page wheel
or a cage with free access to a running wheel (HFD Ex) for 4 wk.
HFD Ex mice had a significant reduction in body weight (Fig. 1A)
that was not due to a significant difference in food intake between
the exercise and sedentary mice (Fig. 1B and Supplemental Fig.
S1; https://doi.org/10.6084/m9.figshare.12170451.v1). Percent
body fat decreased when mice transitioned from a sedentary
(21.9% body fat, week 8, Pre) to exercised (13.1% body fat, week
12, Post) condition (Fig. 1C). Yet, the HFD Sed group had no
change in fat mass over the 4-wk period (pre, 23.1% to Post,
23.5%). Lean mass (Fig. 1D) and fluid mass (Fig. 1E), when
expressed as a percentage of total body weight, was increased in
HFD Ex mice (⫹4.8%) compared with HFD Sed mice (⫺3.0%).
All adipose tissue depots were reduced in mass in mice following
VWR compared with sedentary controls (Fig. 1F). On average
HFD Ex mice ran 5.8 (⫾1.7) km/day with a range of 4.3 to 8.5
km/day. Time effects refer to differences between Pre and Post
measurements. Activity effects refer to differences between Sed
and Ex mice. Time ⫻ activity indicates an interaction.
Glucose tolerance. To assess glucose dynamics, we performed an OGTT with two stable isotopes (SI). The SI-OGTT
can distinguish between exogenous glucose and endogenous
sources of glucose. A typical OGTT is shown in Fig. 2A, where
glucose measurements were assessed with a glucometer and
represents both labeled and unlabeled glucose. As shown in
Fig. 2B, whole blood glucose AUC following the SI-OGTT

500
400

B
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Activity Effect P=0.006
Time x Activity Effect P=0.003

**
##

Time Effect P<0.05
Time x Activity Effect P<0.05

#
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A

was not different between the HFD Sed and HFD Ex before
randomization at 8 wk (Pre). However, following the 4-wk
VWR intervention, exercised mice had a significant reduction
in the glucose AUC compared with the sedentary controls.
Serum insulin measured at time 0 and 15 min after glucose
gavage did not differ between groups before randomization
(Fig. 2C). Yet, insulin levels were reduced in the HFD exercised mice compared with sedentary conditions (Fig. 2C).
Serum NEFA levels were not different between the sedentary
and exercised groups both pre- and postintervention (Fig. 2D).
As expected, HOMA-IR was significantly (P ⬍ 0.001) reduced
in the exercised group (Fig. 2E).
SI-OGTT. The utilization of complementary stable isotope
tracers 2-[2H]-glucose and 6,6-[2H]-glucose allows for the
ability to separate administered glucose (labeled glucose) vs.
endogenous glucose (unlabeled glucose) and provides an index
of the suppression of endogenous glucose production (EGP)
and dynamic glucose disposal. Before randomization (Pre),
there were no differences for endogenous glucose, 2-[2H]glucose and 6,6-[2H]-glucose AUC between the two groups of
mice (Fig. 3, A–C). However, HFD exercised mice had a
reduction in endogenous glucose AUC (Pre vs. Post) and
between groups of mice (exercised vs. sedentary). After conducting a repeated measures two-way ANOVA, we detected
significantly lower endogenous glucose levels at the 0-, 60-,
and 120-min time points for the glycemic fluctuations (Fig.
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Fig. 2. Blood glucose area under the curve (AUC) and insulin response are improved postexercise in high fat-fed mice. Mice were gavaged with glucose
(2-[2H]-glucose and 6,6-[2H]-glucose; 2 g/kg lean body mass), and blood glucose was measured over 120 min with a handheld glucometer. Serum was collected
at 0 and 15 min postgavage for measurement of insulin and nonesterified fatty acids (NEFA). Whole blood glucose glycemic excursion (A) and AUC (B) are
shown for week 8 (Pre) and week 12 (Post). Serum insulin (C), NEFA (D), and homeostatic model analysis of insulin resistance (HOMA-IR; E) are provided
for week 12 (Post). Time effect refers to difference between pre-and postexercise measurements. Activity effect refers to difference between Sed and Ex mice.
Time ⫻ activity indicates an interaction. All data are expressed as means ⫾ SE. *P ⬍ 0.01, **P ⬍ 0.001, ***P ⬍ 0.001, #P ⬍ 0.01, ##P ⬍ 0.001 represents
within-group effects; n ⫽ 13/group.
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Fig. 3. Dynamic glucose responses are altered in response to exercise. Serum after the glucose gavage (2-[2H]-glucose and 6,6 [2H]-glucose; 2 g/kg lean body
mass) was collected, and glucose tracer concentration was determined. Tracerless glucose represents nonadministered endogenous glucose (A and D), 2-[2H]
glucose (B and E), 6,6-[2H] glucose (C and F) concentrations, and hepatic futile cycle (G) were measured during the stable isotope-labeled oral glucose tolerance
test (SI-OGTT) at Pre (week 8) and Post (week 12). Time effect refers to difference between pre- and post-measurements. Activity effect refers to the difference
between Sed and Ex mice. Time ⫻ activity indicates an interaction. All data are expressed as means ⫾ SE. *P ⬍ 0.01, **P ⬍ 0.001, ***P ⬍ 0.001, #P ⬍ 0.01,
##P ⬍ 0.001, within-group effect; n ⫽ 13/group.

3D). The shape of the endogenous glucose excursion curve
where it dips between 15 and 30 min post- glucose gavage
coincides with the progressive increase in exogenous, isotopically labeled glucose. This is also the period when insulin
secretion increases (Fig. 2C), demonstrating the capacity, albeit low, for insulin to suppress hepatic glucose release. There
were no significant differences between groups in the measurement of 2-[2H]-glucose and 6,6-[2H]-glucose AUC and glycemic fluctuations (Fig. 3, A and E and B and F, respectively).
Hepatic futile glucose cycling was measured by subtracting the
AUC for 2-[2H]-glucose from 6 to 6-[2H]-glucose AUC (Fig.
3G) (25). We did not detect any significant effects for time
(P ⫽ 0.85) or for group (P ⫽ 0.58)
Serum and tissue triglycerides and glycogen. VWR results
in a significant reduction in triacylglycerol (TAG) levels in
serum (Fig. 4A) and the liver (Fig. 4B) compared with sedentary controls. Conversely, muscle TAG levels were increased,

but not significant, in HFD Ex vs. Sed mice (Fig. 4C). Notably,
there was a compelling trend for a reduction in liver glycogen
content (P ⬍ 0.057) in exercised mice compared with sedentary controls. However, there were no differences detected in
skeletal muscle (mixed gastrocnemius muscle) glycogen content between the two groups (Fig. 4E).
Protein abundance and gene expression. Ten minutes before
euthanasia, mice in each were group were injected with vehicle
(HFD Sed, n ⫽ 7; HFD Ex, n ⫽ 8) or insulin (HFD Sed, n ⫽
6; HFD Ex, n ⫽ 5). Insulin sensitivity was assessed in skeletal
muscle (gastrocnemius) and the liver by examining acute
insulin induction of Akt phosphorylation. As shown in Fig. 5A,
there was a significant in both HFD Sed mice (P ⫽ 0.002) and
HFD Ex mice (P ⫽ 0.01) increase in phosphorylation of Akt
(AktS473) following acute insulin treatment. Insulin induction
of liver Akt phosphorylation was significantly increased in
HFD Ex mice (P ⫽ 0.05), but not HFD Sed mice (P ⫽ 0.80)
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(Fig. 5C). Basal phosphorylation of AMPK (AMPKThr172) in
skeletal muscle was significant elevated in HFD Ex mice (P ⫽
0.002) compared with HFD Sed mice (Fig. 5B). There was no
difference in liver pAMPK between groups (P ⫽ HFD Sed vs.
HFD Ex, P ⫽ 0.18) (Fig. 5D). Muscle PDK4 protein abundance tended to be increased in exercised mice, but did not
reach statistical significance (P ⫽ 0.09) (Fig. 5B). Liver PDK4
levels were not significantly different between the groups (P ⫽
0.29) (Fig. 5D). PDK4 migrates at 42 kDa, indicated by the
arrow in the figure, but we did find a nonspecific band at 38
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DISCUSSION

Regular aerobic exercise improves muscle glucose uptake
and insulin sensitivity in humans with T2D (16, 45). In rodent
models of DIO, consumption of a HFD and the accompanying
increase in adiposity leads to an insulin-resistant/glucose-intolerant state (46). VWR is commonly utilized to replicate
exercising training due its unforced nature and propensity for
mice to run between 5 and 10 km/day (32). Daily VWR can
improve many aspects of metabolic health in high fat-fed mice
and rats. However, to date, only a few reports have been
published regarding VWR and insulin sensitivity as measured
by the euglycemic-hyperinsulinemic clamp method in DIO rats
(11, 12, 23, 30), with no reports in the VWR-trained high
fat-fed C57BL/6J mice. Furthermore, there are no studies examining the adaptations over time that occur in dynamic glucose
disposal in rodent-models of DIO in response to wheel running.
Therefore, we sought to measure dynamic glucose disposal using
two complementary stable isotopes of deuterium glucose (2-[2H]glucose and 6,6-[2H]-glucose) to measure dynamic glucose disposal in response to 4 wk of VWR in a DIO mice.
There are discrepancies in the literature regarding the impact
of VWR on body weight/body fat reduction in DIO mice (21,
33). In our study, we observed a significant reduction in body
weight after 3 and 4 wk of VWR in high fat-fed mice compared

with sedentary controls (Fig. 1A). The reduction in body
weight was accompanied by a reduction in the percentage body
fat between the sedentary and exercised mice (Fig. 1C). Also,
percent lean body mass was higher in exercised mice after 1
mo but did not differ compared with absolute lean mass (Fig.
1D). We did not measure any significant differences in food
intake (Fig. 1B) between the two groups over the course of the
study. Hence, the increased energy expenditure that occurs
with VWR without a compensatory increase in food intake
likely explains the overall differences we observed in body
mass and composition.
Despite apparent fasting and postprandial hyperinsulinemia (Fig. 2A), sedentary mice had both increased fasting
and OGTT blood glucose levels compared with the exercised group. The major advantage of using the SI-OGTT is
that it permits the blood glucose concentration to be partitioned into what is derived from exogenous (oral glucose)
and endogenous (produced by liver and kidneys) sources,
permitting an index of glucose disposal and pattern of EGP to
be estimated. 2-[2H]-glucose is subjected to hepatic futile
cycling, whereas 6,6-[2H]-glucose is not. Therefore, we were
able to measure glucose disposal and hepatic futile cycling. We
did not detect a large degree of hepatic futile cycling in
sedentary or exercised mice (Fig. 3G). This is consistent with
previous reports showing long duration (42 wk) feeding of a
HFD, high-sucrose diet was necessary to induce hepatic futile
cycling (28, 29). It is possible that the 45% HFD used in the
current study is not a sufficient metabolic challenge to induce
a loss of hepatic efficiency. Therefore, future implementation
of this aspect of the SI-OGTT may be more appropriate for
animals undergoing more severe metabolic challenges for longer periods of time. For comparison of glucose disposal and
endogenous glucose, the sole use of 6,6-[2H]-glucose, without
2-[2H]-glucose, will provide valuable information in less severe models of insulin resistance.
Acute and chronic exercise improve insulin sensitivity in
both human and animal models (10, 16, 39). Improved insulin
sensitivity in the immediate and extended time period after
exercise (3– 4 h) is thought to be linked to reduced skeletal
muscle glycogen content (9, 39). Chronic exercise adaptations
are thought to occur via more effective intracellular insulin
signaling and improved mitochondrial capacity to oxidize
lipids, thereby reducing substrate competition in skeletal muscle (4, 17, 25). Interestingly, after 4 wk of wheel running,
exercised mice did not have significant alterations in muscle
glycogen levels; however, there was a strong trend (P ⫽ 0.057)
for lower liver glycogen content (Fig. 4D). Our observations
are consistent with other studies showing that VWR reduced
liver glycogen content in a dose-dependent (volume of daily
wheel running per day) manner (10). The exercise mice in our
study did demonstrate a significant improvement in insulin
sensitivity as evaluated by HOMA-IR (Fig. 2E). Since
HOMA-IR incorporates fasted blood glucose and insulin levels, these observations also support an improvement in hepatic
glucose metabolism, but not necessarily alterations in dynamic
glucose disposal. Mice engaging in wheel running or forced
treadmill running do not require muscle glycogen, but can
maintain energy needs through gluconeogenesis and glycogenolysis in the liver (37). After exhaustive exercise, muscle
glycogen levels are replenished preferentially upon refeeding
after exercise (9). However, in our exercise model, VWR likely
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did not promote exhaustion. Low-, moderate-, and high-dose
insulin tolerance testing may provide unique insight into tissuespecific adaptations to VWR.
Importantly, liver and serum TAG levels were markedly
reduced in exercised mice while muscle levels were not significantly different (Fig. 4), findings that have previously been
reported in 4-wk exercise-trained HFD-fed mice (20). During
acute exercise, C57BL/6J mice increase hepatic glucose production to maintain glycemia via increased glycogenolysis and
gluconeogenesis (17). Considering the similar trends in glucose tracer (6,6-2[H] glucose) disposal and the differential
pattern of endogenous glucose levels during the OGTT between the sedentary and exercised mice, these data suggest that
adaptations in the liver may explain the improvement in glycemia that occur with VWR.
In our studies, muscle insulin signaling was significantly
increased in both sedentary and exercised mice, but not the
increase in insulin-mediated phosphorylation of Akt was not
greater in the HFD Ex mice. This observation is not surprising
in a consideration of evidence that phosphorylation of Akt is
not necessary for exercise-induced improvements in insulin
sensitivity (8). However, we did detect a significant increase in
hepatic insulin-mediated Akt phosphorylation in HFD Ex mice
compared with HFD Sed mice. Our in vivo SI-OGTT also
supports an improved hepatic response to glucose and insulin for
HFD Ex mice. Additionally, hepatic FOXO1 mRNA levels were
elevated in the exercised group, suggesting that at least some
aspect of gluconeogenesis was altered due to wheel running.
There were discrepancies between pAMPK levels in skeletal
muscle and liver protein levels (Fig. 5). Exercise increased
pAMPK levels significantly, but not in the liver (HFD Ex vs. HFD
Sed). This observation is somewhat expected in the consideration
of data that show that forced treadmill exercise in the fasted state
was required to increase muscle and hepatic AMP levels (2).
However, this result could also be considered somewhat unexpected given the near significant reduction in hepatic glycogen
content measured in exercised mice (Fig. 4D). Overall, these
observations may reflect the adapted state to lower hepatic glycogen content rather than acute activation of AMPK via increased
AMP accumulation. The increase in skeletal muscle phosphorylation of AMPK would suggest smaller perturbation in the energetic state can sufficiently activate this pathway.
PDK4 is a negative regulator of the PDH complex and
reduces pyruvate flux into the mitochondria to favor fatty acid
oxidation (4). Skeletal muscle PDK4 protein levels trended to
be increased in HFD Ex mice, which likely corresponds to a
greater shift toward fat oxidation. Interestingly, while protein
content in the liver for PDK4 was not different between
sedentary and exercised groups, PDK4 mRNA levels were
significantly reduced in exercised mice (Fig. 6). These data
demonstrate the known differential responses to exercise between skeletal muscle and the liver (15, 19, 24, 38, 40).
Increased PKD4 in the skeletal muscle likely promotes the
glycogen synthetic response by preserving gluconeogenic substrates derived from pyruvate (15). Whereas reduced PDK4
mRNA levels in the liver are associated with the promotion of
glucose oxidation (38). Similarly, genetic inactivation of liver
PKD4 markedly improves hepatic insulin resistance and reduces hepatic glucose production, suggesting that control of
hepatic PKD4 expression plays a role in mediating the metabolic effects of exercise (35, 42).
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After oral glucose ingestion, glucose disposal is shared
primarily between the skeletal muscle and the liver (~30% for
both tissues) (18, 22, 36). Oral glucose tolerance testing provides a physiological route for glucose to promote insulin
secretion; however, factors such as EGP and glucose disposal
remain unknown. The improved efficiency of liver glucose
uptake and suppression of glucose output is not often considered in the adaptations to exercise training. The startling
worldwide upsurge in fatty liver diseases emphasizes the importance of exploring hepatic adaptations to exercise training.
To our knowledge, this is the first report to demonstrate
postprandial glucose dynamics using stable isotope tracers in
exercising high fat-fed mice influenced by reduced fasting
glucose and lower endogenous glucose excursion in response
to VWR. Overall, these observations expand our knowledge of
the physiological adaptations that occur in this well-studied
mouse model of metabolic disease.
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